Latest Developments in Global Liquid Crystal Polymer For Medical Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Liquid Crystal Polymer For Medical Market

  • Healthcare
  • Nov 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In March 2023, Solvay, a leader in specialized materials, introduced a new high-heat and flame-retardant grade to its Xydar® liquid crystal polymer (LCP) portfolio. This addition is aimed at meeting the stringent safety requirements for electric vehicle battery components. By expanding its LCP offerings, Solvay continues to enhance its capabilities to support the growing demand for advanced materials in the automotive industry
  • In January 2022, Sumitomo Chemical announced the expansion of additional production lines for its liquid crystal polymer (LCP) SUMIKASUPERTM at its Ehime Works in Niihama, Japan. This expansion aims to increase the Group's production capacity by around 30%. LCP is produced at both Sumitomo Chemical’s Ehime Works and the Harima Works of its subsidiary, Taoka Chemical Co., Ltd., supporting the growing demand for high-performance engineering plastics
  • In January 2021, Celanese Corporation unveiled plans for a new greenfield manufacturing facility in China to meet the rapidly increasing demand for liquid crystal polymers. The first phase of the project is expected to be completed by 2024, with an annual production capacity of 20,000 tons. This expansion highlights the company's commitment to addressing market growth and strengthening its presence in the region

Frequently Asked Questions